Literature DB >> 2764368

The influence of refractoriness to adenosine 5'-monophosphate on allergen-provoked bronchoconstriction in asthma.

G D Phillips1, P K Bagga, R Djukanovic, S T Holgate.   

Abstract

Repeated bronchoprovocation with adenosine 5'-monophosphate (AMP) in atopic, nonasthmatic subjects produces a state of refractoriness to the nucleotide that may be due either to depletion of preformed mediators from airway mast cells or down-regulation of purinoceptors on the surface of these cells. To investigate this further, we compared the effect on immediate allergen-provoked bronchoconstriction of preceding repeated challenges with histamine and AMP in eight atopic, mildly asthmatic subjects. In three successive AMP concentration-response studies, the geometric mean PC20 AMP increased from 275.3 to 1154.3 (p less than 0.01) and 1976.7 (p less than 0.01) mg/ml, respectively, whereas no significant similar increase in PC20 occurred with repeated histamine challenges. Refractoriness to AMP was not associated with any significant decrease in airways responsiveness to histamine. When compared with the response after repeated provocation with inhaled histamine, repeated exposure of the airways to AMP potentiated, rather than inhibited, immediate allergen-induced bronchoconstriction by a mean 57 +/- 22.6% (p less than 0.05) when the data were expressed as the area under the FEV1-time response curve. The ability of airways that have been rendered less responsive to inhaled AMP to exhibit an increased response to allergen suggests that tachyphylaxis to AMP is unlikely to be caused by depletion of preformed mast cell-derived mediators such as histamine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764368     DOI: 10.1164/ajrccm/140.2.321

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

Review 1.  Adenosine bronchoconstriction in asthma: investigations into its possible mechanism of action.

Authors:  W H Ng; R Polosa; M K Church
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

2.  Cross refractoriness between sodium metabisulphite and exercise induced asthma.

Authors:  I Pavord; H Lazarowicz; D Inchley; D Baldwin; A Knox; A Tattersfield
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

3.  The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma.

Authors:  Stephen T Holgate
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs.

Authors:  C A Lewis; K J Broadley
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Adenosine-induced bronchoconstriction of isolated lung and trachea from sensitized guinea-pigs.

Authors:  J R Thorne; K J Broadley
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

6.  The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics.

Authors:  Dave Singh; Jennifer Fairwood; Robert Murdoch; Amanda Weeks; Paul Russell; Kay Roy; Steve Langley; Ashley Woodcock
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.